4 and a half months - Progress
    4/19/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Ketoconazole →

    antifungal with some anti-androgenic benefits, often used as a shampoo

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 0.5mg 4.5 months
    💧 Minoxidil (topical) once a day 4.5 months
    Ketoconazole (shampoo) 2-3 times a week 4.5 months
    💧 Derma stamp (topical) 0.5mm twice recently started
    the tone is 😀 positive with positive hair regrowth results.

    Other terms

    A 33-year-old is experiencing positive hair regrowth after 4.5 months using 0.5mg finasteride, topical minoxidil, ketoconazole shampoo, and a 0.5mm derma stamp. They had initial shedding but now see less hair loss, with no sexual side effects and improved libido.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Medical Treatments for Male and Female Pattern Hair Loss

      research Medical treatments for male and female pattern hair loss

      212 citations , September 2008 in “Journal of The American Academy of Dermatology”
      This review discusses the various treatment options for male and female pattern hair loss and provides no new clinical results; the authors outline the most effective strategies based on existing evidence.
      Male Androgenetic Alopecia

      research Male androgenetic alopecia

      100 citations , April 2010 in “Expert Opinion on Pharmacotherapy”
      This article reviews existing treatments for male-pattern hair loss, noting that while they can slow progression, they generally achieve only partial hair regrowth.
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.